[From The Age, Jan 30, 2016] Access to a drug lauded for halting the spread of HIV will be provided to more than 2500 people in a push to wipe out new infections.
A major expansion of a trial for the Pre-exposure Prophylaxis (PReP) drug will begin later this year for people at high risk of contracting the disease.